Pharmadule Morimatsu to Present Modular Build Advantage in California

Nacka, Stockholm: – Swedish-based designer and builder of modular production facilities for the pharma and biopharma industries, Pharmadule Morimatsu AB (Pharmadule) will present the design and build advantages of its distinctive modular approach when it attends the second Flexible Facilities conference in Berkley, California next month.

Exciting Developments
“We had no hesitation in returning to the Flexible Facilities show,” said Ulf Danielsson, Pharmadule Morimatsu Executive VP, Sales & Marketing. “We are a natural fit for this event, since the Pharmadule proposition is the very definition of flexible manufacturing facilities.”

“This event addresses the benefits and challenges of flexible facilities and plays an influential role in showing how the future almost certainly belongs to “adaptable” and flexible designs and facilities of the kind that Pharmadule has helped to pioneer,” said Mr. Danielsson.

“It will also present new concepts and pipeline strategies for future pharmaceutical development of the kind we are keen to talk about.”

“Finally, this conference offers a good balance of executive level considerations and in-the-field technical details to inform those in the biopharma industry that operate multi-product facilities or design flexible production spaces,” added Mr. Danielsson.

Flexible Manufacturing Solutions
Pharmadule Morimatsu will be present at Stand 200 at the Claremont Hotel, prepared to provide details of its offerings, including turnkey design and construction services, modular off-site production solutions, commissioning and qualification expertise, GMP consultancy and extended after-sales services.

The company will also be using the exhibition’s networking opportunities to identify forthcoming project leads and partners, reaching out to executive and senior managers in engineering & facilities, process technology, process science, operations/facility development and biopharmaceutical operations.

“We aim to demonstrate how our leading-edge modular production models and all-enveloping services that extends from concept to delivery and beyond remove risk and uncertainty for the client”, said Mr. Danielsson.

“It’s also important for potential partners to understand how our industry-focused expertise adds value to every stage of the process. For example, we will be showing how we can deploy expertise within commissioning and qualification, by performing IQ and OQ according to current GMP standards and adopting the ‘Lifecycle’ structure from the FDA Process Validation Guide.”

About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities for the pharma and biopharma Industries. Pharmadule services extend from conceptual design to IQ/OQ completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance and Validation Management.

The company was founded in 1986, since which time it has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca. In forging The Pharmadule Way to offer unique value and reassurance to customers, with off-site construction and modular design concepts, Pharmadule provides very high predictability of on time, on budget delivery and consistent high quality, regardless of the final project location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.

About Flexible Facilities 2014
The second annual Flexible Facilities conference and exhibition will take place February 24-25, 2014, at the Claremont Hotel & Spa in Berkeley, California. The event, hosted by IBC Life Sciences, will again focus on innovative biopharmaceutical manufacturing solutions for multi-product pipelines, global markets, on-Demand upscale and downscale site changes and capacity optimization.

The sell-out inaugural event in 2013 attracted around 100 senior level executives and scientists from biopharma companies, CMO’s, technology providers, engineering firms and regulatory groups.

Once again, the conference will explore the changing landscape of biologics manufacturing and share case studies of the latest flexible facility implementations, lessons learned and practical experiences.

Presentations will cover current and future state-of-the-art innovations in flexible technology, facility design and process design, focusing on the technical, business, regulatory and economic considerations, as well as the opportunities and challenges of creating flexible production facilities for biopharma organizations.

Contact:
Pharmadule Morimatsu AB
Maria Rosén, Director of Marketing
Tel: +46 (0)8 587 42 000
Email: [email protected]

For more information about Pharmadule Morimatsu design and build modular approach, please contact Pharmadule Morimatsu directly.